Archive | ARTES Biotechnology GmbH

Home / Archive

Establishment of a yeast-based VLP platform for antigen presentation

Wednesday 21st February 2018

By ARTES Biotechnology… Learn More >

ARTES brings new vaccine advances to veterinary ‘Dragons’ Den’

Monday 5th February 2018

By ARTES Biotechnology… Learn More >

ARTES seeking new collaborations at BioFIT 2017

Friday 24th November 2017

By ARTES Biotechnology… Learn More >

ARTES receives French CIR Research Tax Credit Accreditation

Tuesday 21st November 2017

By ARTES Biotechnology… Learn More >

EU patent grant for ARTES Biotechnology METAVAX®

Tuesday 22nd August 2017

By ARTES Biotechnology… Learn More >

ARTES White Paper outlines high-yield production process for secreted and active Invertase

Tuesday 15th August 2017

By ARTES Biotechnology… Learn More >

Cell line development based on efficient high-yield microbial expression platforms

Monday 3rd July 2017

By ARTES Biotechnology… Learn More >

BioSimilars – Technology Transfer

Tuesday 23rd May 2017

By ARTES Biotechnology… Learn More >

METAVAX® – Proprietary Innovative Vaccine Platform

Wednesday 10th May 2017

By ARTES Biotechnology… Learn More >

ARTES enters Animal Health Investment Dragons Den

Monday 13th February 2017

By ARTES Biotechnology… Learn More >

ARTES in co-development deal for HPV vaccine

Monday 30th January 2017

By ARTES Biotechnology… Learn More >

ARTES in partnership to develop novel hepatitis C vaccine

Friday 5th August 2016

By ARTES Biotechnology… Learn More >